U.S. Digital Forensics Stock Hits 52-Week Low, $370 Billion Market Cap Vanishes in a Day

Cellebrite DI Ltd. (NASDAQ: CLBT) plunged 11.12% on the 10th, closing at $11.03 and nearing its 52-week low. Its market capitalization fell to about $2.75 billion (roughly ₩3.7 trillion), wiping out approximately $275 million (around ₩370 billion) in a single day.

On the same day, Investing.com reported that Cellebrite’s share price hit an intraday low of $11.76, setting a new 52-week trough. Despite reporting fourth-quarter 2025 results that exceeded analysts’ revenue and earnings estimates, Needham cut its price target from $24 to $18, a conservative outlook that has weighed on the stock. In its full-year 2025 earnings release, however, the company highlighted double-digit growth in both revenue and annual recurring revenue (ARR) and provided guidance for 19–20% growth in both metrics in 2026—signaling that its core growth story remains intact.

Headquartered in Petah Tikva, Israel, Cellebrite is a digital forensics and intelligence firm that delivers mobile and cloud data extraction and analysis solutions to law enforcement agencies and enterprises worldwide. Best known for its UFED iPhone-unlocking tool, the company’s focus on government clients carries inherent risks: past dealings with authoritarian regimes and privacy concerns have drawn criticism from human rights organizations.